FDA Inspection 1082467 — Joslin Diabetes Center Committee On Human Studies
The FDA completed an inspection of Joslin Diabetes Center Committee On Human Studies on Nov 27, 2018 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 27, 2018
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional details
IRB